This inventor holds 1 USPTO granted patent. Top assignee: Arjil Biotech Holding Company Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Cheng Huang: Innovator in Viral Infection Prevention
Introduction
Cheng Huang is a notable inventor based in Taipei City, Taiwan. He has made significant contributions to the field of virology through his innovative research and development of compounds aimed at preventing viral infections.
Latest Patents
Cheng Huang holds a patent for a "Method and composition for inhibiting virus infection." This invention pertains to a compound, particularly ovatodiolide, which is used in preventing or treating infections caused by various viruses. These include hepatitis virus, influenza virus, herpes simplex virus, enterovirus, rotavirus, dengue virus, poxvirus, human immunodeficiency virus, adenovirus, coronavirus, arenavirus, measles virus, retrovirus, and norovirus, particularly SARS-COV-2. The patent also outlines methods for utilizing this compound in pharmaceutical compositions to combat viral infections.
Career Highlights
Cheng Huang is associated with Arjil Biotech Holding Company Limited, where he continues to advance his research in biotechnology and virology. His work is pivotal in developing effective treatments for viral infections, which have significant implications for public health.
Conclusion
Cheng Huang's innovative contributions to the field of virology, particularly through his patented methods and compositions, highlight his role as a key inventor in the fight against viral infections. His ongoing work at Arjil Biotech Holding Company Limited promises to further enhance our understanding and treatment of viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile